Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Aurinia Pharmaceuticals Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
AUPH (Aurinia Pharmaceuticals Inc.) has 2 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
No intraday reading yet this session.
281 institutional managers report a position in Aurinia Pharmaceuticals Inc. worth $1.4B between them, filed on form 13F for the quarter ending 2026-06-30. 32 of them hold 80% of it, the largest being Tang Capital Management LLC at 16.18%.
256 more managers in the register
32 managers hold 80% of the $1.4B institutional base. The other 249 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Tang Capital Management LLC, Marshall Wace LLP, Caption Management, LLC · 16.18% of AUPH, 18.52% of NNDM
via Tang Capital Management LLC, Marshall Wace LLP, Jacobs Levy Equity Management, Inc +2 more · 16.18% of AUPH, 12.72% of PLRX
via Tang Capital Management LLC, Marshall Wace LLP, State of Wisconsin Investment Board · 16.18% of AUPH, 15.06% of DERM
via Tang Capital Management LLC · 16.18% of AUPH, 16.73% of BOLD
via Tang Capital Management LLC, Caption Management, LLC · 16.18% of AUPH, 14.56% of NVCT
via Tang Capital Management LLC, Marshall Wace LLP · 16.18% of AUPH, 12.31% of PMVP
Managers holding a meaningful stake in AUPH also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.